Latest news with #SanjeevBhatt
Time of India
3 days ago
- Business
- Time of India
ADIA invests $200 million in medical devices co Meril
Representative image NEW DELHI: Abu Dhabi Investment Authority (ADIA), UAE's largest sovereign wealth fund, has entered into a definitive agreement to invest $200 million (around Rs 1,700 crore) for a 3% stake in Meril (Micro Life Sciences), a medical devices company. This investment values Meril at an enterprise value of $6.6 billion (around Rs 56,000 crore), says a company statement. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this deal, Meril will be backed by two globally recognised investors — ADIA and Warburg Pincus, it adds. In 2022, Warburg Pincus announced that it will invest $210 million for a minority stake in Meril. Sanjeev Bhatt, senior vice president — strategy, Meril, said: 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions. This investment will enable us to accelerate growth, attract worldclass talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Founded by the Bilakhia Group, Meril has a strong focus on clinically-advanced solutions across multiple specialties — including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics. Headquartered in Vapi (Gujarat), Meril operates state-of-theart, vertically integrated, and globally certified manufacturing and R&D facilities. Established in 1976, ADIA is a globally diversified investment institution that invests funds on behalf of the Abu Dhabi govt through a strategy focused on long-term value creation. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Economic Times
3 days ago
- Business
- Economic Times
ADIA signs a definitive agreement to invest $200 million in medical devices firm Meril
Abu Dhabi Investment Authority (ADIA) has signed a definitive agreement to invest $200 million (about Rs1,725 crore) for a 3% stake in medical devices maker Micro Life Sciences Pvt Ltd (Meril). The investment by a wholly-owned subsidiary of ADIA pegged Meril's enterprise valuation at $6.6 billion, the Vapi, Gujarat-based company said in a statement. Post the investment, Meril will be backed by two major global investors ADIA, and US private equity firm Warburg Pincus. The deal is subject to Competition Commission of India (CCI) approval. 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions,' said Sanjeev Bhatt, senior vice president-strategy at Meril. 'This investment will enable us to accelerate growth, attract world-class talent, and further strengthen clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Meril was founded in 2006 by the Bilakhia Group after divesting their agrochemical business to Bayer, and the Micro lnks business to Hubergroup—both from Germany. In 2022, the promoters tapped Warburg Pincus to raise Rs 1,575 crore by selling a 14% stake in Meril, and Rohit Kothari's Anchorage Capital for Rs 200 crore by divesting a 2% stake at a valuation of about Rs 11,000 crore. In the three years since, Meril closed fundraisings for another 3% shareholdings while its valuation surged more than fivefold to nearly Rs 60,000 crore. The Bilakhia family currently has more than 81% stake in the company, with Warburg, ADIA, and Kothari being other principal shareholders together holding nearly 19%.Meril is regarded as an innovator in medical technology (MedTech), with a focus on clinically-advanced solutions across multiple specialties such as cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics. Some of the innovations include transcatheter heart valve series, transcatheter edge-to-edge repair system, and surgical robotic system. The company is growing between 30-35% compounded annually, with FY25 revenue at Rs 4,800 crore and margins of 27-28%. Exports contributed about 55% of expect the company to double revenue within less than three years. Meril employs more than 13,000 employees and has over 35 global subsidiaries. Its Vapi facility spans over 100 acres with over 1 million sq ft manufacturing space.
Time of India
3 days ago
- Business
- Time of India
ADIA signs a definitive agreement to invest $200 million in medical devices firm Meril
Abu Dhabi Investment Authority (ADIA) is set to invest $200 million for a 3% stake in medical device maker Meril, valuing the company at $6.6 billion. This investment, pending CCI approval, will support Meril's growth and research efforts. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Abu Dhabi Investment Authority (ADIA) has signed a definitive agreement to invest $200 million (about Rs1,725 crore) for a 3% stake in medical devices maker Micro Life Sciences Pvt Ltd ( Meril ).The investment by a wholly-owned subsidiary of ADIA pegged Meril's enterprise valuation at $6.6 billion, the Vapi, Gujarat-based company said in a the investment, Meril will be backed by two major global investors ADIA, and US private equity firm Warburg Pincus . The deal is subject to Competition Commission of India (CCI) approval.'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions,' said Sanjeev Bhatt, senior vice president-strategy at Meril. 'This investment will enable us to accelerate growth, attract world-class talent, and further strengthen clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions .'Meril was founded in 2006 by the Bilakhia Group after divesting their agrochemical business to Bayer, and the Micro lnks business to Hubergroup—both from 2022, the promoters tapped Warburg Pincus to raise Rs 1,575 crore by selling a 14% stake in Meril, and Rohit Kothari's Anchorage Capital for Rs 200 crore by divesting a 2% stake at a valuation of about Rs 11,000 crore. In the three years since, Meril closed fundraisings for another 3% shareholdings while its valuation surged more than fivefold to nearly Rs 60,000 Bilakhia family currently has more than 81% stake in the company, with Warburg, ADIA, and Kothari being other principal shareholders together holding nearly 19%.Meril is regarded as an innovator in medical technology (MedTech), with a focus on clinically-advanced solutions across multiple specialties such as cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics. Some of the innovations include transcatheter heart valve series, transcatheter edge-to-edge repair system, and surgical robotic company is growing between 30-35% compounded annually, with FY25 revenue at Rs 4,800 crore and margins of 27-28%. Exports contributed about 55% of expect the company to double revenue within less than three employs more than 13,000 employees and has over 35 global subsidiaries. Its Vapi facility spans over 100 acres with over 1 million sq ft manufacturing space.
&w=3840&q=100)
Business Standard
3 days ago
- Business
- Business Standard
Abu Dhabi Investment Authority buys 3% stake in Meril for $200 million
Abu Dhabi Investment Authority acquires a 3% stake in Meril for $200 million, valuing the Gujarat-based medical devices maker at $6.6 billion. The deal is pending approval from CCI BS Reporter New Delhi Abu Dhabi Investment Authority (ADIA) on Monday announced that it will acquire a 3 per cent stake in Gujarat-based medical devices manufacturer Meril for an investment of $200 million (approximately ₹1,723 crore). According to Meril, a wholly owned subsidiary of ADIA has signed definitive agreements to invest in the company. The deal values Meril at $6.6 billion (around ₹56,859 crore) and is pending approval from the Competition Commission of India (CCI). 'Post this investment, Meril will be backed by two globally recognised investors, ADIA and Warburg Pincus,' the medical device maker added. Meril develops and manufactures cardiovascular devices, structural heart solutions, surgical robotics, orthopaedic implants, in-vitro diagnostics, and endo-surgery technologies. The company had recently invested ₹1,400 crore in a facility in Vapi. Commenting on the deal, Sanjeev Bhatt, Senior Vice President for Strategy at Meril, said that the investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions. 'It will enable us to accelerate growth, attract world-class talent, and further strengthen our research and development and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions,' he added.
Mint
3 days ago
- Business
- Mint
ADIA to Invest USD 200 Million in Meril
Vapi, India– [21 July 2025] – A wholly owned subsidiary of the Abu Dhabi Investment Authority ('ADIA') has entered into definitive agreements to invest USD 200 million for a ~3% stake in Micro Life Sciences Private Limited ('Meril'), one of India's leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus. Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics. Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities, across a 100 acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world's leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation. Meril With a robust in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril's dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually. Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: 'This investment by ADIA reinforces confidence in Meril's long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Meril is a global medical technology company headquartered in Vapi, India. With a strong emphasis on innovation, Meril develops clinically meaningful products aimed at enhancing patient outcomes across cardiovascular, orthopaedic, diagnostic, Endo Surgery and robotic surgery domains. Founded by the Bilakhia Group, the company is committed to sustainability, quality, and global impact. For more information: About Abu Dhabi Investment Authority (ADIA) Established in 1976, the Abu Dhabi Investment Authority ('ADIA') is a globally-diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long-term value creation. For more information: Media contact :media@ Note to readers: This article is part of Mint's paid consumer connect Initiative. Mint assumes no editorial involvement or responsibility for errors, omissions, or content accuracy. Want to get your story featured as above?click here!
